The DTP3 immunization coverage forecast for children aged 1 in the U.S. remains constant at 94% from 2024 to 2028, signaling a stable outlook compared to 2023, when the coverage was at a similar level. There is no year-on-year variation, thus the Compound Annual Growth Rate (CAGR) for the period is 0%. This stability suggests a highly effective immunization program maintaining consistent coverage levels.

Future trends to watch for include:

Potential changes in public health policy that might aim to either sustain or increase current immunization rates.
Impact of emerging diseases or vaccine hesitancy that could influence these projections.
The role of technological advancements in vaccine distribution and administration efficiency.